Why It Matters
Americans for Pharma Reform Inc. filed its first lobbying registration on Oct. 23, retaining Connector Inc. to cover Pharmacy (PHA) and Trade (Domestic & Foreign) (TRD) issue areas.
The lobbying team is Morgan Muchnick, Vice President, who has Senate Homeland Security and Governmental Affairs Committee staff experience, and Rob Burgess, Chief Executive Officer, who previously served as Communications Director in the personal offices of Rep. Trey Hollingsworth (R-IN-9) and Rep. Mike Garcia (R-CA-27).
Broader Context
The Federal Trade Commission's January 2025 interim staff report found the three largest pharmacy benefit managers marked up many specialty generic drugs dispensed through affiliated pharmacies, generating more than $7.3 billion in dispensing revenue above estimated acquisition costs from 2017 to 2022, according to the FTC. Executive Order 14297, issued May 12, 2025, set a federal policy goal of giving U.S. patients access to most-favored-nation prices for prescription drugs and biologics, directed agencies to communicate price targets to manufacturers, and outlined a rulemaking plan if significant progress was not made.
Between The Lines
Rep. Anna Paulina Luna (R-FL-13) called on House leadership in November 2025 to bring PBM reform legislation to the floor, writing that "patients come before profits." In a September 1, 2026, post on X, she said Congress should cap prescription drug prices. Sen. Chuck Grassley (R-IA) backed the bipartisan INSULIN Act in March 2026 to cap insulin at $35 and enact PBM reform, citing rebate practices by Big Pharma and PBMs.
Competitive Landscape
Blue Cross and Blue Shield of North Carolina registered in-house on Oct. 21, covering pharmacy, health, taxation, and Medicare/Medicaid issues. Domtar Corp. retained Greenberg Traurig LLP on Oct. 21 to lobby on trade issues. Aluminum Extruders Council hired Wessel Group Inc. on Oct. 20 to lobby on trade.
The Bottom Line
The filing is the organization's only lobbying disclosure on record, and Legis1 shows $30,000 in lobbying expense over the past four quarters, all through Connector Inc.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article
